Free Trial

Xylem (XYL) Financials

Xylem logo
$125.59 -0.65 (-0.51%)
Closing price 05/28/2025 03:59 PM Eastern
Extended Trading
$126.41 +0.82 (+0.65%)
As of 05/28/2025 07:16 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for Xylem

Annual Income Statements for Xylem

This table shows Xylem's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Net Income / (Loss) Attributable to Common Shareholders
890 609 355 427 254 401 549 331 260 340
Consolidated Net Income / (Loss)
890 609 355 427 254 401 549 330 260 340
Net Income / (Loss) Continuing Operations
890 609 355 427 254 401 549 330 260 340
Total Pre-Tax Income
1,087 635 440 511 285 416 585 466 340 403
Total Operating Income
1,009 652 622 585 367 486 654 552 408 449
Total Gross Profit
3,212 2,717 2,084 1,975 1,830 2,046 2,026 1,847 1,462 1,404
Total Revenue
8,562 7,364 5,522 5,195 4,876 5,249 5,207 4,707 3,771 3,653
Operating Revenue
8,562 7,364 5,522 5,195 4,876 5,249 5,207 4,707 3,771 3,653
Total Cost of Revenue
5,350 4,647 3,438 3,220 3,046 3,203 3,181 2,860 2,309 2,249
Operating Cost of Revenue
5,350 4,647 3,438 3,220 3,046 3,203 3,181 2,860 2,309 2,249
Total Operating Expenses
2,203 2,065 1,462 1,390 1,463 1,560 1,372 1,295 1,054 955
Selling, General & Admin Expense
1,911 1,757 1,227 1,179 1,143 1,158 1,161 1,089 914 854
Research & Development Expense
230 232 206 204 187 191 189 181 110 95
Impairment Charge
62 76 29 7.00 133 211 22 0.00 - -
Other Special Charges / (Income)
0.00 0.00 - 0.00 0.00 - - - - -
Total Other Income / (Expense), net
78 -17 -182 -74 -82 -70 -69 -86 -68 -46
Interest Expense
44 49 50 76 77 67 82 82 70 55
Interest & Investment Income
152 0.00 0.00 - - - - - - -
Other Income / (Expense), net
-30 32 -132 2.00 -5.00 -3.00 13 -4.00 2.00 9.00
Income Tax Expense
197 26 85 84 31 15 36 136 80 63
Basic Earnings per Share
$3.67 $2.81 $1.97 $2.37 $1.41 $2.23 $3.05 $1.84 $1.45 $1.88
Weighted Average Basic Shares Outstanding
242.58M 217.01M 180.22M 180.25M 180.12M 179.99M 179.78M 179.60M 179.11M 180.89M
Diluted Earnings per Share
$3.65 $2.79 $1.96 $2.35 $1.40 $2.21 $3.03 $1.83 $1.45 $1.87
Weighted Average Diluted Shares Outstanding
243.52M 218.18M 180.98M 181.53M 181.10M 181.20M 181.13M 180.90M 180.04M 181.74M
Weighted Average Basic & Diluted Shares Outstanding
243.05M 241.77M 180.28M 179.90M 180.36M 180.22M 180M 179.90M 179.30M 180.90M
Cash Dividends to Common per Share
$1.44 $1.32 $1.20 $1.12 $1.04 $0.96 $0.84 $0.72 $0.62 $0.56

Quarterly Income Statements for Xylem

This table shows Xylem's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Income / (Loss) Attributable to Common Shareholders
169 326 217 194 153 266 152 92 99 149 12
Consolidated Net Income / (Loss)
167 326 217 194 153 266 152 92 99 149 12
Net Income / (Loss) Continuing Operations
167 326 217 194 153 266 152 92 99 149 12
Total Pre-Tax Income
217 375 269 247 196 210 185 114 126 189 17
Total Operating Income
231 267 280 253 209 211 191 119 131 197 168
Total Gross Profit
768 857 784 819 752 756 764 651 546 573 524
Total Revenue
2,069 2,256 2,104 2,169 2,033 2,118 2,076 1,722 1,448 1,506 1,380
Operating Revenue
2,069 2,256 2,104 2,169 2,033 2,118 2,076 1,722 1,448 1,506 1,380
Total Cost of Revenue
1,301 1,399 1,320 1,350 1,281 1,362 1,312 1,071 902 933 856
Operating Cost of Revenue
1,301 1,399 1,320 1,350 1,281 1,362 1,312 1,071 902 933 856
Total Operating Expenses
537 590 504 566 543 545 573 532 415 376 356
Selling, General & Admin Expense
460 507 445 485 474 466 491 446 354 315 294
Research & Development Expense
56 58 55 58 59 60 61 58 53 54 47
Impairment Charge
21 25 4.00 23 10 19 21 28 8.00 7.00 15
Total Other Income / (Expense), net
-14 108 -11 -6.00 -13 -1.00 -6.00 -5.00 -5.00 -8.00 -151
Interest Expense
8.00 9.00 10 11 14 14 14 12 9.00 13 12
Other Income / (Expense), net
-6.00 -35 -1.00 5.00 1.00 13 8.00 7.00 4.00 5.00 -139
Income Tax Expense
50 49 52 53 43 -56 33 22 27 40 5.00
Net Income / (Loss) Attributable to Noncontrolling Interest
-2.00 - - - - - - - - - -
Basic Earnings per Share
$0.69 $1.35 $0.89 $0.80 $0.63 $1.18 $0.63 $0.45 $0.55 $0.83 $0.07
Weighted Average Basic Shares Outstanding
243.11M 242.58M 242.93M 242.57M 241.85M 217.01M 240.87M 205.54M 180.40M 180.22M 180.22M
Diluted Earnings per Share
$0.69 $1.33 $0.89 $0.80 $0.63 $1.17 $0.63 $0.45 $0.54 $0.82 $0.07
Weighted Average Diluted Shares Outstanding
243.78M 243.52M 243.75M 243.54M 243.02M 218.18M 242.19M 206.74M 181.32M 180.98M 180.94M
Weighted Average Basic & Diluted Shares Outstanding
243.35M 243.05M 242.94M 242.89M 242.45M 241.77M 241.08M 240.83M 180.62M 180.28M 180.22M
Cash Dividends to Common per Share
$0.40 - $0.36 - - - $0.33 - - - $0.30

Annual Cash Flow Statements for Xylem

This table details how cash moves in and out of Xylem's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Net Change in Cash & Equivalents
102 75 -405 -526 1,151 428 -118 106 -372 17
Net Cash From Operating Activities
1,263 837 596 538 824 839 586 686 497 464
Net Cash From Continuing Operating Activities
1,263 837 596 538 824 839 586 686 497 464
Net Income / (Loss) Continuing Operations
890 609 355 427 254 401 549 330 260 340
Consolidated Net Income / (Loss)
890 609 355 427 254 401 549 330 260 340
Depreciation Expense
258 193 111 118 117 117 117 109 87 88
Amortization Expense
304 243 125 127 134 140 144 125 64 45
Non-Cash Adjustments To Reconcile Net Income
-9.00 112 182 17 178 229 20 42 27 -1.00
Changes in Operating Assets and Liabilities, net
-180 -320 -177 -151 141 -48 -244 80 59 -8.00
Net Cash From Investing Activities
-482 -628 -191 -183 -169 -231 -643 -181 -1,886 -132
Net Cash From Continuing Investing Activities
-482 -628 -191 -183 -169 -231 -643 -181 -1,886 -132
Purchase of Property, Plant & Equipment
-321 -271 -208 -208 -183 -226 -237 -170 -124 -117
Acquisitions
-199 -533 -3.00 -5.00 - -18 -433 -33 -1,782 -18
Purchase of Investments
-11 -1.00 -21 0.00 -200 -7.00 -11 -11 0.00 0.00
Sale of Property, Plant & Equipment
4.00 1.00 4.00 3.00 - - - 1.00 1.00 0.00
Divestitures
11 105 1.00 10 0.00 0.00 22 16 0.00 1.00
Sale and/or Maturity of Investments
35 29 33 14 212 20 11 10 0.00 0.00
Other Investing Activities, net
-1.00 42 3.00 3.00 2.00 0.00 5.00 6.00 19 2.00
Net Cash From Financing Activities
-615 -157 -790 -855 473 -177 -40 -421 1,034 -262
Net Cash From Continuing Financing Activities
-615 -157 -790 -855 473 -177 -40 -421 1,034 -262
Repayment of Debt
-313 -173 -529 -603 -642 -257 -172 -282 -688 -4.00
Repurchase of Common Equity
-20 -25 -52 -68 -61 -40 -59 -25 -4.00 -179
Payment of Dividends
-350 -299 -217 -203 -188 -174 -152 -130 -112 -102
Issuance of Debt
1.00 278 0.00 0.00 1,344 281 336 0.00 1,814 0.00
Other Financing Activities, net
67 62 8.00 19 20 13 7.00 16 24 23
Effect of Exchange Rate Changes
-53 23 -20 -26 23 -3.00 -21 22 -17 -53
Cash Interest Paid
67 69 76 99 77 77 78 78 49 52
Cash Income Taxes Paid
219 211 91 83 41 107 75 57 78 75

Quarterly Cash Flow Statements for Xylem

This table details how cash moves in and out of Xylem's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Change in Cash & Equivalents
-62 132 174 -132 -72 314 -3.00 -129 -107 -242 73
Net Cash From Operating Activities
33 575 311 288 89 455 373 28 -19 362 202
Net Cash From Continuing Operating Activities
33 575 311 288 89 455 373 28 -19 362 202
Net Income / (Loss) Continuing Operations
169 326 217 194 153 266 152 92 99 149 12
Consolidated Net Income / (Loss)
169 326 217 194 153 266 152 92 99 149 12
Depreciation Expense
68 67 68 62 61 61 63 41 28 28 27
Amortization Expense
77 75 73 83 73 76 84 51 32 32 31
Non-Cash Adjustments To Reconcile Net Income
54 -91 18 33 31 30 24 35 23 2.00 150
Changes in Operating Assets and Liabilities, net
-335 198 -65 -84 -229 22 50 -191 -201 151 -18
Net Cash From Investing Activities
-15 -289 -65 -77 -51 -89 -50 -452 -37 -68 -39
Net Cash From Continuing Investing Activities
-15 -289 -65 -77 -51 -89 -50 -452 -37 -68 -39
Purchase of Property, Plant & Equipment
-71 -100 -74 -73 -74 -94 -74 -54 -49 -60 -53
Acquisitions
-8.00 -190 -2.00 - - 1.00 -2.00 - - -1.00 -1.00
Purchase of Investments
0.00 -3.00 -1.00 -5.00 -2.00 - -1.00 - 0.00 -12 -2.00
Sale of Property, Plant & Equipment
5.00 1.00 - 2.00 1.00 -1.00 2.00 - 0.00 1.00 -
Divestitures
48 - - - 11 2.00 12 91 0.00 - -
Sale and/or Maturity of Investments
12 5.00 12 5.00 13 3.00 12 1.00 13 4.00 14
Other Investing Activities, net
-1.00 -2.00 - 1.00 0.00 - 1.00 42 -1.00 - 3.00
Net Cash From Financing Activities
-116 -95 -101 -337 -82 -86 -306 298 -63 -580 -52
Net Cash From Continuing Financing Activities
-116 -95 -101 -337 -82 -86 -306 298 -63 -580 -52
Repayment of Debt
-12 -9.00 -15 -277 -12 -10 -157 -4.00 -2.00 -528 -2.00
Repurchase of Common Equity
-13 -1.00 -1.00 -3.00 -15 -15 -1.00 -1.00 -8.00 - -
Payment of Dividends
-98 -87 -88 -87 -88 -80 -80 -79 -60 -54 -53
Issuance of Debt
1.00 1.00 - - - 2.00 -73 - - - -
Other Financing Activities, net
6.00 1.00 3.00 30 33 17 5.00 33 7.00 2.00 3.00
Effect of Exchange Rate Changes
25 -48 29 -6.00 -28 34 -20 -3.00 12 44 -38
Other Net Changes in Cash
11 - - - - - - - - - -
Cash Interest Paid
12 18 13 23 13 26 13 19 11 9.00 27
Cash Income Taxes Paid
37 59 50 71 39 52 24 86 49 34 15

Annual Balance Sheets for Xylem

This table presents Xylem's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Total Assets
16,493 16,112 7,952 8,276 8,750 7,710 7,222 6,860 6,474 4,657
Total Current Assets
4,098 3,884 3,012 3,160 3,523 2,450 2,094 2,071 1,839 2,005
Cash & Equivalents
1,121 1,019 944 1,349 1,875 724 296 414 308 680
Accounts Receivable
1,668 1,617 1,096 953 923 1,036 1,031 956 843 749
Inventories, net
996 1,018 799 700 558 539 595 524 522 433
Prepaid Expenses
236 230 173 158 167 151 172 177 166 143
Other Current Nonoperating Assets
77 0.00 - - - - - - - -
Plant, Property, & Equipment, net
1,152 1,169 630 644 657 658 656 643 616 439
Total Noncurrent Assets
11,243 11,059 4,310 4,472 4,570 4,602 4,472 4,146 4,019 2,213
Goodwill
7,980 7,587 2,719 2,792 2,854 2,839 2,976 2,768 2,632 1,584
Intangible Assets
2,379 2,529 930 1,016 1,093 1,174 1,232 1,168 1,201 435
Other Noncurrent Operating Assets
884 943 661 664 623 589 264 210 186 194
Total Liabilities & Shareholders' Equity
16,493 16,112 7,952 8,276 8,750 7,710 7,222 6,860 6,474 4,657
Total Liabilities
5,611 5,936 4,449 5,050 5,774 4,743 4,440 4,341 4,267 2,573
Total Current Liabilities
2,336 2,205 1,590 1,391 1,956 1,501 1,389 1,100 1,238 823
Short-Term Debt
38 16 0.00 - 600 276 257 0.00 260 78
Accounts Payable
1,006 968 723 639 569 597 586 549 457 338
Accrued Expenses
1,271 1,221 867 752 787 628 546 551 521 407
Other Current Nonoperating Liabilities
21 0.00 - - - - - - - -
Total Noncurrent Liabilities
3,275 3,731 2,859 3,659 3,818 3,242 3,051 3,241 3,029 1,750
Long-Term Debt
1,978 2,268 1,880 2,440 2,484 2,040 2,051 2,200 2,108 1,196
Noncurrent Deferred & Payable Income Tax Liabilities
497 557 222 287 242 310 303 252 352 118
Noncurrent Employee Benefit Liabilities
304 344 286 438 519 445 400 442 408 335
Other Noncurrent Operating Liabilities
496 562 471 494 573 447 297 347 161 101
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest
235 0.00 - - - - - - - -
Total Equity & Noncontrolling Interests
10,647 10,176 3,503 3,226 2,976 2,967 2,782 2,519 2,207 2,084
Total Preferred & Common Equity
10,642 10,166 3,494 3,218 2,968 2,957 2,768 2,503 2,190 2,084
Total Common Equity
10,642 10,166 3,494 3,218 2,968 2,957 2,768 2,503 2,190 2,084
Common Stock
8,690 8,567 2,136 2,091 2,039 1,993 1,952 1,914 1,878 1,836
Retained Earnings
3,140 2,601 2,292 2,154 1,930 1,866 1,639 1,227 1,033 885
Treasury Stock
-753 -733 -708 -656 -588 -527 -487 -428 -403 -399
Accumulated Other Comprehensive Income / (Loss)
-435 -269 -226 -371 -413 -375 -336 -210 -318 -238
Noncontrolling Interest
5.00 10 9.00 8.00 8.00 10 14 16 17 0.00

Quarterly Balance Sheets for Xylem

This table presents Xylem's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Total Assets
16,559 16,493 16,046 15,765 15,924 16,112 15,905 16,097 7,940 7,952 8,106
Total Current Assets
4,084 4,098 4,013 3,781 3,893 3,884 3,651 3,735 3,010 3,012 3,191
Cash & Equivalents
1,059 1,121 989 815 947 1,019 705 708 837 944 1,186
Accounts Receivable
1,743 1,668 1,707 1,675 1,641 1,617 1,653 1,659 1,123 1,096 1,018
Inventories, net
1,022 996 1,091 1,057 1,039 1,018 1,080 1,143 857 799 837
Prepaid Expenses
260 236 226 234 266 230 213 225 193 173 150
Other Current Nonoperating Assets
0.00 77 - - - 0.00 - - - - -
Plant, Property, & Equipment, net
1,157 1,152 1,158 1,144 1,141 1,169 1,132 1,144 631 630 585
Total Noncurrent Assets
11,318 11,243 10,875 10,840 10,890 11,059 11,122 11,218 4,299 4,310 4,330
Goodwill
8,061 7,980 7,593 7,509 7,509 7,587 7,149 7,108 2,738 2,719 2,637
Intangible Assets
2,332 2,379 2,326 2,374 2,454 2,529 3,039 3,188 915 930 933
Other Noncurrent Operating Assets
925 884 956 957 927 943 934 922 646 661 760
Total Liabilities & Shareholders' Equity
16,559 16,493 16,046 15,765 15,924 16,112 15,905 16,097 7,940 7,952 8,106
Total Liabilities
5,505 5,611 5,446 5,417 5,721 5,936 5,964 6,187 4,351 4,449 4,884
Total Current Liabilities
2,166 2,336 2,052 2,042 2,331 2,205 2,120 2,282 1,494 1,590 1,929
Short-Term Debt
41 38 17 17 285 16 17 240 0.00 0.00 483
Accounts Payable
958 1,006 930 940 948 968 943 968 710 723 618
Accrued Expenses
1,167 1,271 1,105 1,085 1,098 1,221 1,160 1,074 784 867 828
Other Current Nonoperating Liabilities
0.00 21 - - - 0.00 - - - - -
Total Noncurrent Liabilities
3,339 3,275 3,394 3,375 3,390 3,731 3,844 3,905 2,857 2,859 2,955
Long-Term Debt
1,974 1,978 1,977 1,981 1,985 2,268 2,253 2,267 1,881 1,880 1,880
Noncurrent Deferred & Payable Income Tax Liabilities
486 497 535 552 558 557 724 738 215 222 260
Noncurrent Employee Benefit Liabilities
317 304 332 325 323 344 281 293 285 286 361
Other Noncurrent Operating Liabilities
562 496 550 517 524 562 586 607 476 471 454
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest
232 235 - - - 0.00 - - - - -
Total Equity & Noncontrolling Interests
10,822 10,647 10,600 10,348 10,203 10,176 9,941 9,910 3,589 3,503 3,222
Total Preferred & Common Equity
10,816 10,642 10,593 10,341 10,195 10,166 9,930 9,899 3,578 3,494 3,215
Total Common Equity
10,816 10,642 10,593 10,341 10,195 10,166 9,930 9,899 3,578 3,494 3,215
Common Stock
8,708 8,690 8,676 8,663 8,621 8,567 8,532 8,498 2,154 2,136 2,125
Retained Earnings
3,211 3,140 2,902 2,774 2,667 2,601 2,416 2,344 2,331 2,292 2,197
Treasury Stock
-766 -753 -753 -751 -748 -733 -718 -717 -716 -708 -708
Accumulated Other Comprehensive Income / (Loss)
-337 -435 -232 -345 -345 -269 -300 -226 -191 -226 -399
Noncontrolling Interest
6.00 5.00 7.00 7.00 8.00 10 11 11 11 9.00 7.00

Annual Metrics And Ratios for Xylem

This table displays calculated financial ratios and metrics derived from Xylem's official financial filings.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Growth Metrics
- - - - - - - - - -
Revenue Growth
16.27% 33.36% 6.29% 6.54% -7.11% 0.81% 10.62% 24.82% 3.23% -6.72%
EBITDA Growth
37.59% 54.27% -12.74% 35.73% -17.16% -20.26% 18.67% 39.39% -5.08% -4.21%
EBIT Growth
43.13% 39.59% -16.52% 62.15% -25.05% -27.59% 21.72% 33.66% -10.48% -3.58%
NOPAT Growth
32.12% 24.60% 2.66% 49.45% -30.18% -23.67% 57.01% 25.29% -17.64% 2.21%
Net Income Growth
46.14% 71.55% -16.86% 68.11% -36.66% -26.96% 66.36% 26.92% -23.53% 0.89%
EPS Growth
30.82% 42.35% -16.60% 67.86% -36.65% -27.06% 65.57% 26.21% -22.46% 2.19%
Operating Cash Flow Growth
50.90% 40.44% 10.78% -34.71% -1.79% 43.17% -14.58% 38.03% 7.11% 11.54%
Free Cash Flow Firm Growth
108.56% -1,778.78% 6.45% -49.10% -0.34% 463.89% -64.65% 127.64% -384.53% -21.48%
Invested Capital Growth
2.45% 157.74% 2.83% 3.15% -8.20% -4.90% 11.36% 0.89% 59.34% -2.55%
Revenue Q/Q Growth
1.64% 9.06% 3.43% -0.95% 0.04% -0.29% 2.14% 4.02% 2.75% -1.30%
EBITDA Q/Q Growth
0.85% 9.70% 9.67% -4.91% -2.70% -0.80% 4.50% 8.31% -1.58% -0.51%
EBIT Q/Q Growth
0.82% 3.32% 14.75% -6.38% -3.72% -1.02% 5.37% 10.93% -7.24% 0.22%
NOPAT Q/Q Growth
-3.70% 22.31% 4.97% -7.93% 16.28% -20.71% 34.50% 6.90% -17.08% 5.83%
Net Income Q/Q Growth
7.23% 23.78% 11.29% -7.58% 13.39% -21.06% 39.34% 6.45% -19.75% 5.59%
EPS Q/Q Growth
4.58% 14.34% 11.36% -7.84% 13.82% -21.07% 38.99% 6.40% -19.44% 6.86%
Operating Cash Flow Q/Q Growth
10.50% 12.50% 31.28% -21.80% -2.14% 29.28% -15.68% 13.95% 3.97% 9.69%
Free Cash Flow Firm Q/Q Growth
-28.04% 3.32% -0.32% -40.02% 1.12% 23.24% -31.20% 126.35% -518.30% -19.13%
Invested Capital Q/Q Growth
1.00% -0.56% 0.91% 0.35% -4.15% -4.58% 0.76% -3.97% 53.60% -1.07%
Profitability Metrics
- - - - - - - - - -
Gross Margin
37.51% 36.90% 37.74% 38.02% 37.53% 38.98% 38.91% 39.24% 38.77% 38.43%
EBITDA Margin
18.00% 15.21% 13.15% 16.02% 12.57% 14.10% 17.82% 16.61% 14.88% 16.18%
Operating Margin
11.78% 8.85% 11.26% 11.26% 7.53% 9.26% 12.56% 11.73% 10.82% 12.29%
EBIT Margin
11.43% 9.29% 8.87% 11.30% 7.42% 9.20% 12.81% 11.64% 10.87% 12.54%
Profit (Net Income) Margin
10.39% 8.27% 6.43% 8.22% 5.21% 7.64% 10.54% 7.01% 6.89% 9.31%
Tax Burden Percent
81.88% 95.91% 80.68% 83.56% 89.12% 96.39% 93.85% 70.82% 76.47% 84.37%
Interest Burden Percent
111.03% 92.84% 89.80% 87.05% 78.73% 86.13% 87.71% 85.04% 82.93% 87.99%
Effective Tax Rate
18.12% 4.09% 19.32% 16.44% 10.88% 3.61% 6.15% 29.18% 23.53% 15.63%
Return on Invested Capital (ROIC)
7.13% 7.88% 11.46% 11.50% 7.48% 10.02% 13.49% 9.12% 8.98% 13.96%
ROIC Less NNEP Spread (ROIC-NNEP)
13.20% 6.39% -3.03% 6.12% 2.26% 6.27% 10.08% 5.95% 5.07% 7.57%
Return on Net Nonoperating Assets (RNNOA)
1.32% 1.03% -0.91% 2.27% 1.07% 3.93% 7.22% 4.84% 3.13% 2.19%
Return on Equity (ROE)
8.45% 8.90% 10.55% 13.77% 8.55% 13.95% 20.71% 13.97% 12.12% 16.15%
Cash Return on Invested Capital (CROIC)
4.72% -80.31% 8.68% 8.39% 16.04% 15.04% 2.74% 8.23% -36.77% 16.54%
Operating Return on Assets (OROA)
6.01% 5.68% 6.04% 6.90% 4.40% 6.47% 9.47% 8.22% 7.37% 9.65%
Return on Assets (ROA)
5.46% 5.06% 4.38% 5.02% 3.09% 5.37% 7.80% 4.95% 4.67% 7.17%
Return on Common Equity (ROCE)
8.35% 8.89% 10.52% 13.73% 8.52% 13.89% 20.60% 13.87% 12.07% 16.15%
Return on Equity Simple (ROE_SIMPLE)
8.36% 5.99% 10.16% 13.27% 8.56% 13.56% 19.83% 13.18% 11.87% 16.31%
Net Operating Profit after Tax (NOPAT)
826 625 502 489 327 468 614 391 312 379
NOPAT Margin
9.65% 8.49% 9.09% 9.41% 6.71% 8.93% 11.79% 8.30% 8.27% 10.37%
Net Nonoperating Expense Percent (NNEP)
-6.07% 1.48% 14.49% 5.38% 5.22% 3.74% 3.41% 3.17% 3.92% 6.39%
Return On Investment Capital (ROIC_SIMPLE)
6.52% 5.02% 9.32% - - - - - - -
Cost of Revenue to Revenue
62.49% 63.10% 62.26% 61.98% 62.47% 61.02% 61.09% 60.76% 61.23% 61.57%
SG&A Expenses to Revenue
22.32% 23.86% 22.22% 22.69% 23.44% 22.06% 22.30% 23.14% 24.24% 23.38%
R&D to Revenue
2.69% 3.15% 3.73% 3.93% 3.84% 3.64% 3.63% 3.85% 2.92% 2.60%
Operating Expenses to Revenue
25.73% 28.04% 26.48% 26.76% 30.00% 29.72% 26.35% 27.51% 27.95% 26.14%
Earnings before Interest and Taxes (EBIT)
979 684 490 587 362 483 667 548 410 458
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
1,541 1,120 726 832 613 740 928 782 561 591
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
2.64 2.67 5.55 6.51 5.93 4.55 4.05 4.52 3.70 2.83
Price to Tangible Book Value (P/TBV)
99.29 543.69 0.00 0.00 0.00 0.00 0.00 0.00 0.00 90.65
Price to Revenue (P/Rev)
3.28 3.69 3.51 4.03 3.61 2.56 2.15 2.41 2.15 1.61
Price to Earnings (P/E)
31.57 44.64 54.64 49.08 69.34 33.52 20.43 34.21 31.19 17.33
Dividend Yield
1.25% 1.17% 1.12% 0.96% 1.06% 1.29% 1.35% 1.14% 1.37% 1.71%
Earnings Yield
3.17% 2.24% 1.83% 2.04% 1.44% 2.98% 4.89% 2.92% 3.21% 5.77%
Enterprise Value to Invested Capital (EV/IC)
2.49 2.49 4.58 5.11 4.50 3.30 2.76 3.05 2.39 2.42
Enterprise Value to Revenue (EV/Rev)
3.41 3.86 3.68 4.25 3.86 2.87 2.54 2.79 2.70 1.78
Enterprise Value to EBITDA (EV/EBITDA)
18.97 25.41 28.02 26.51 30.71 20.33 14.27 16.79 18.16 10.98
Enterprise Value to EBIT (EV/EBIT)
29.86 41.61 41.51 37.57 52.01 31.15 19.86 23.95 24.84 14.16
Enterprise Value to NOPAT (EV/NOPAT)
35.39 45.51 40.53 45.12 57.56 32.11 21.58 33.58 32.65 17.12
Enterprise Value to Operating Cash Flow (EV/OCF)
23.15 34.00 34.13 41.00 22.85 17.93 22.60 19.14 20.49 13.98
Enterprise Value to Free Cash Flow (EV/FCFF)
53.53 0.00 53.55 61.81 26.86 21.39 106.16 37.20 0.00 14.45
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
0.19 0.22 0.54 0.76 1.04 0.78 0.83 0.87 1.07 0.61
Long-Term Debt to Equity
0.18 0.22 0.54 0.76 0.83 0.69 0.74 0.87 0.96 0.57
Financial Leverage
0.10 0.16 0.30 0.37 0.47 0.63 0.72 0.81 0.62 0.29
Leverage Ratio
1.55 1.76 2.41 2.75 2.77 2.60 2.66 2.82 2.59 2.25
Compound Leverage Factor
1.72 1.63 2.17 2.39 2.18 2.24 2.33 2.40 2.15 1.98
Debt to Total Capital
15.63% 18.33% 34.92% 43.06% 50.89% 43.84% 45.34% 46.62% 51.76% 37.94%
Short-Term Debt to Total Capital
0.29% 0.13% 0.00% 0.00% 9.90% 5.22% 5.05% 0.00% 5.68% 2.32%
Long-Term Debt to Total Capital
15.34% 18.20% 34.92% 43.06% 40.99% 38.61% 40.29% 46.62% 46.08% 35.62%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
1.86% 0.08% 0.17% 0.14% 0.13% 0.19% 0.28% 0.34% 0.37% 0.00%
Common Equity to Total Capital
82.51% 81.59% 64.91% 56.79% 48.98% 55.97% 54.38% 53.04% 47.87% 62.06%
Debt to EBITDA
1.31 2.04 2.59 2.93 5.03 3.13 2.49 2.81 4.22 2.16
Net Debt to EBITDA
0.58 1.13 1.29 1.31 1.97 2.15 2.17 2.28 3.67 1.01
Long-Term Debt to EBITDA
1.28 2.03 2.59 2.93 4.05 2.76 2.21 2.81 3.76 2.02
Debt to NOPAT
2.44 3.65 3.75 4.99 9.43 4.94 3.76 5.63 7.59 3.36
Net Debt to NOPAT
1.08 2.02 1.87 2.23 3.70 3.40 3.28 4.57 6.60 1.57
Long-Term Debt to NOPAT
2.39 3.63 3.75 4.99 7.59 4.35 3.34 5.63 6.76 3.16
Altman Z-Score
4.11 3.70 4.13 3.97 3.05 3.07 2.98 2.94 2.27 3.05
Noncontrolling Interest Sharing Ratio
1.19% 0.14% 0.25% 0.26% 0.30% 0.42% 0.57% 0.70% 0.40% 0.00%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
1.75 1.76 1.89 2.27 1.80 1.63 1.51 1.88 1.49 2.44
Quick Ratio
1.19 1.20 1.28 1.65 1.43 1.17 0.96 1.25 0.93 1.74
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
546 -6,377 380 357 701 703 125 353 -1,277 449
Operating Cash Flow to CapEx
398.42% 310.00% 292.16% 262.44% 450.27% 371.24% 247.26% 405.92% 404.07% 396.58%
Free Cash Flow to Firm to Interest Expense
12.41 -130.14 7.60 4.70 9.10 10.50 1.52 4.30 -18.24 8.16
Operating Cash Flow to Interest Expense
28.70 17.08 11.92 7.08 10.70 12.52 7.15 8.37 7.10 8.44
Operating Cash Flow Less CapEx to Interest Expense
21.50 11.57 7.84 4.38 8.32 9.15 4.26 6.30 5.34 6.31
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.53 0.61 0.68 0.61 0.59 0.70 0.74 0.71 0.68 0.77
Accounts Receivable Turnover
5.21 5.43 5.39 5.54 4.98 5.08 5.24 5.23 4.74 4.81
Inventory Turnover
5.31 5.12 4.59 5.12 5.55 5.65 5.69 5.47 4.84 4.89
Fixed Asset Turnover
7.38 8.19 8.67 7.99 7.42 7.99 8.02 7.48 7.15 8.12
Accounts Payable Turnover
5.42 5.50 5.05 5.33 5.22 5.42 5.61 5.69 5.81 6.65
Days Sales Outstanding (DSO)
70.02 67.24 67.72 65.90 73.32 71.87 69.64 69.75 77.05 75.94
Days Inventory Outstanding (DIO)
68.70 71.36 79.57 71.30 65.73 64.61 64.20 66.75 75.48 74.57
Days Payable Outstanding (DPO)
67.34 66.41 72.30 68.47 69.86 67.40 65.12 64.19 62.84 54.86
Cash Conversion Cycle (CCC)
71.38 72.18 74.99 68.74 69.19 69.07 68.72 72.30 89.69 95.66
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
11,721 11,441 4,439 4,317 4,185 4,559 4,794 4,305 4,267 2,678
Invested Capital Turnover
0.74 0.93 1.26 1.22 1.12 1.12 1.14 1.10 1.09 1.35
Increase / (Decrease) in Invested Capital
280 7,002 122 132 -374 -235 489 38 1,589 -70
Enterprise Value (EV)
29,234 28,459 20,341 22,056 18,828 15,044 13,244 13,127 10,186 6,486
Market Capitalization
28,099 27,184 19,396 20,957 17,611 13,442 11,218 11,325 8,109 5,892
Book Value per Share
$43.80 $42.17 $19.39 $17.85 $16.47 $16.42 $15.40 $13.94 $12.21 $11.62
Tangible Book Value per Share
$1.16 $0.21 ($0.86) ($3.27) ($5.43) ($5.86) ($8.01) ($7.98) ($9.16) $0.36
Total Capital
12,898 12,460 5,383 5,666 6,060 5,283 5,090 4,719 4,575 3,358
Total Debt
2,016 2,284 1,880 2,440 3,084 2,316 2,308 2,200 2,368 1,274
Total Long-Term Debt
1,978 2,268 1,880 2,440 2,484 2,040 2,051 2,200 2,108 1,196
Net Debt
895 1,265 936 1,091 1,209 1,592 2,012 1,786 2,060 594
Capital Expenditures (CapEx)
317 270 204 205 183 226 237 169 123 117
Debt-free, Cash-free Net Working Capital (DFCFNWC)
679 676 478 420 292 501 666 557 553 580
Debt-free Net Working Capital (DFNWC)
1,800 1,695 1,422 1,769 2,167 1,225 962 971 861 1,260
Net Working Capital (NWC)
1,762 1,679 1,422 1,769 1,567 949 705 971 601 1,182
Net Nonoperating Expense (NNE)
-64 16 147 62 73 67 65 61 52 39
Net Nonoperating Obligations (NNO)
839 1,265 936 1,091 1,209 1,592 2,012 1,786 2,060 594
Total Depreciation and Amortization (D&A)
562 436 236 245 251 257 261 234 151 133
Debt-free, Cash-free Net Working Capital to Revenue
7.93% 9.18% 8.66% 8.08% 5.99% 9.54% 12.79% 11.83% 14.66% 15.88%
Debt-free Net Working Capital to Revenue
21.02% 23.02% 25.75% 34.05% 44.44% 23.34% 18.48% 20.63% 22.83% 34.49%
Net Working Capital to Revenue
20.58% 22.80% 25.75% 34.05% 32.14% 18.08% 13.54% 20.63% 15.94% 32.36%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
$3.67 $2.81 $1.97 $2.37 $1.41 $2.23 $3.05 $1.84 $1.45 $1.88
Adjusted Weighted Average Basic Shares Outstanding
242.58M 217.01M 180.22M 180.25M 180.12M 180M 179.78M 179.63M 179.11M 180.89M
Adjusted Diluted Earnings per Share
$3.65 $2.79 $1.96 $2.35 $1.40 $2.21 $3.03 $1.83 $1.45 $1.87
Adjusted Weighted Average Diluted Shares Outstanding
243.52M 218.18M 180.98M 181.53M 181.10M 181.20M 181.13M 180.86M 180.04M 181.74M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
243.05M 241.77M 180.28M 179.90M 180.36M 180.22M 179.55M 179.89M 179.47M 178.49M
Normalized Net Operating Profit after Tax (NOPAT)
877 698 525 495 446 672 634 409 335 384
Normalized NOPAT Margin
10.24% 9.48% 9.51% 9.52% 9.14% 12.80% 12.18% 8.68% 8.88% 10.51%
Pre Tax Income Margin
12.70% 8.62% 7.97% 9.84% 5.85% 7.93% 11.23% 9.90% 9.02% 11.03%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
22.25 13.96 9.80 7.72 4.70 7.21 8.13 6.68 5.86 8.33
NOPAT to Interest Expense
18.78 12.76 10.04 6.43 4.25 6.99 7.48 4.77 4.46 6.89
EBIT Less CapEx to Interest Expense
15.05 8.45 5.72 5.03 2.32 3.84 5.24 4.62 4.10 6.20
NOPAT Less CapEx to Interest Expense
11.57 7.25 5.96 3.73 1.87 3.62 4.59 2.71 2.70 4.76
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
39.33% 49.10% 61.13% 47.54% 74.02% 43.39% 27.69% 39.39% 43.08% 30.00%
Augmented Payout Ratio
41.57% 53.20% 75.77% 63.47% 98.03% 53.37% 38.43% 46.97% 44.62% 82.65%

Quarterly Metrics And Ratios for Xylem

This table displays calculated financial ratios and metrics derived from Xylem's official financial filings.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Growth Metrics
- - - - - - - - - - -
Revenue Growth
1.77% 6.52% 1.35% 25.96% 40.40% 40.64% 50.43% 26.25% 13.84% 13.83% 9.09%
EBITDA Growth
7.56% 3.60% 21.39% 84.86% 76.41% 37.79% 297.70% 4.81% 15.38% 32.32% -59.72%
EBIT Growth
7.14% 3.57% 40.20% 104.76% 55.56% 10.89% 586.21% -14.86% 21.62% 45.32% -81.17%
NOPAT Growth
8.97% -13.15% 43.93% 106.92% 58.51% 72.09% 32.33% -20.13% 10.82% 23.70% -8.98%
Net Income Growth
9.15% 22.56% 42.76% 110.87% 54.55% 78.52% 1,166.67% -17.86% 20.73% 31.86% -89.47%
EPS Growth
9.52% 13.68% 41.27% 77.78% 16.67% 42.68% 800.00% -27.42% 20.00% 32.26% -88.89%
Operating Cash Flow Growth
-62.92% 26.37% -16.62% 928.57% 568.42% 25.69% 84.65% -75.22% 76.54% 64.55% 80.36%
Free Cash Flow Firm Growth
95.45% 99.29% 101.83% 105.29% -83,278.70% -20,320.25% -32,293.79% -7,416.47% 92.74% 616.83% -88.89%
Invested Capital Growth
4.20% 2.45% 0.86% -1.52% 148.78% 157.74% 161.56% 160.78% 2.45% 2.83% 2.25%
Revenue Q/Q Growth
-8.29% 7.22% -3.00% 6.69% -4.01% 2.02% 20.56% 18.92% -3.85% 9.13% 1.17%
EBITDA Q/Q Growth
-1.07% -10.95% 4.22% 17.15% -4.71% 4.34% 58.72% 11.79% -25.57% 201.15% -58.17%
EBIT Q/Q Growth
-3.02% -16.85% 8.14% 22.86% -6.25% 12.56% 57.94% -6.67% -33.17% 596.55% -80.41%
NOPAT Q/Q Growth
-23.41% 2.76% 13.67% 21.80% -38.96% 70.31% 63.41% -6.70% -33.73% 30.96% -1.37%
Net Income Q/Q Growth
-48.77% 50.23% 11.86% 26.80% -42.48% 75.00% 65.22% -7.07% -33.56% 1,141.67% -89.29%
EPS Q/Q Growth
-48.12% 49.44% 11.25% 26.98% -46.15% 85.71% 40.00% -16.67% -34.15% 1,071.43% -88.71%
Operating Cash Flow Q/Q Growth
-94.26% 84.89% 7.99% 223.60% -80.44% 21.98% 1,232.14% 247.37% -105.25% 79.21% 78.76%
Free Cash Flow Firm Q/Q Growth
-539.46% -137.74% -66.32% 105.60% 0.07% 3.10% 2.43% -88,149.12% -124.23% 54.28% 122.78%
Invested Capital Q/Q Growth
2.47% 1.00% 0.64% 0.04% 0.74% -0.56% -1.73% 152.73% 4.37% 0.91% -2.03%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
37.12% 37.99% 37.26% 37.76% 36.99% 35.69% 36.80% 37.80% 37.71% 38.05% 37.97%
EBITDA Margin
17.88% 16.58% 19.96% 18.58% 16.92% 17.04% 16.67% 12.66% 13.47% 17.40% 6.30%
Operating Margin
11.16% 11.84% 13.31% 11.66% 10.28% 9.96% 9.20% 6.91% 9.05% 13.08% 12.17%
EBIT Margin
10.87% 10.28% 13.26% 11.89% 10.33% 10.58% 9.59% 7.32% 9.32% 13.41% 2.10%
Profit (Net Income) Margin
8.07% 14.45% 10.31% 8.94% 7.53% 12.56% 7.32% 5.34% 6.84% 9.89% 0.87%
Tax Burden Percent
76.96% 86.93% 80.67% 78.54% 78.06% 126.67% 82.16% 80.70% 78.57% 78.84% 70.59%
Interest Burden Percent
96.44% 161.64% 96.42% 95.74% 93.33% 93.75% 92.96% 90.48% 93.33% 93.56% 58.62%
Effective Tax Rate
23.04% 13.07% 19.33% 21.46% 21.94% -26.67% 17.84% 19.30% 21.43% 21.16% 29.41%
Return on Invested Capital (ROIC)
6.28% 7.61% 7.83% 6.62% 7.90% 11.70% 6.42% 4.17% 8.85% 13.01% 10.55%
ROIC Less NNEP Spread (ROIC-NNEP)
5.33% 16.53% 7.14% 6.30% 7.04% 11.59% 6.06% 3.91% 8.52% 12.39% 1.58%
Return on Net Nonoperating Assets (RNNOA)
0.57% 1.65% 0.89% 0.93% 1.21% 1.86% 1.26% 0.92% 2.96% 3.73% 0.59%
Return on Equity (ROE)
6.85% 9.26% 8.72% 7.55% 9.10% 13.57% 7.68% 5.09% 11.81% 16.74% 11.14%
Cash Return on Invested Capital (CROIC)
3.04% 4.72% 6.57% 8.32% -76.82% -80.31% -82.94% -83.14% 8.72% 8.68% 8.76%
Operating Return on Assets (OROA)
5.76% 5.40% 6.99% 6.27% 6.88% 6.47% 5.39% 3.65% 6.58% 9.13% 1.38%
Return on Assets (ROA)
4.27% 7.59% 5.44% 4.71% 5.01% 7.69% 4.12% 2.66% 4.82% 6.73% 0.57%
Return on Common Equity (ROCE)
6.77% 9.15% 8.71% 7.54% 9.09% 13.55% 7.67% 5.08% 11.77% 16.70% 11.11%
Return on Equity Simple (ROE_SIMPLE)
8.36% 0.00% 7.84% 7.40% 6.50% 0.00% 4.95% 3.56% 10.40% 0.00% 9.92%
Net Operating Profit after Tax (NOPAT)
178 232 226 199 163 267 157 96 103 155 119
NOPAT Margin
8.59% 10.29% 10.74% 9.16% 8.03% 12.62% 7.56% 5.58% 7.11% 10.31% 8.59%
Net Nonoperating Expense Percent (NNEP)
0.95% -8.92% 0.69% 0.32% 0.86% 0.12% 0.36% 0.26% 0.33% 0.62% 8.97%
Return On Investment Capital (ROIC_SIMPLE)
1.38% 1.83% - - - 2.15% - - - 2.89% -
Cost of Revenue to Revenue
62.88% 62.01% 62.74% 62.24% 63.01% 64.31% 63.20% 62.20% 62.29% 61.95% 62.03%
SG&A Expenses to Revenue
22.23% 22.47% 21.15% 22.36% 23.32% 22.00% 23.65% 25.90% 24.45% 20.92% 21.30%
R&D to Revenue
2.71% 2.57% 2.61% 2.67% 2.90% 2.83% 2.94% 3.37% 3.66% 3.59% 3.41%
Operating Expenses to Revenue
25.95% 26.15% 23.95% 26.10% 26.71% 25.73% 27.60% 30.89% 28.66% 24.97% 25.80%
Earnings before Interest and Taxes (EBIT)
225 232 279 258 210 224 199 126 135 202 29
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
370 374 420 403 344 361 346 218 195 262 87
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
2.68 2.64 3.10 3.18 3.05 2.67 2.18 2.03 5.19 5.55 4.79
Price to Tangible Book Value (P/TBV)
68.64 99.29 48.66 71.80 133.95 543.69 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
3.38 3.28 3.89 3.92 3.91 3.69 3.21 3.32 3.26 3.51 2.89
Price to Earnings (P/E)
32.05 31.57 39.52 42.98 46.87 44.64 44.05 57.10 49.97 54.64 48.31
Dividend Yield
1.24% 1.25% 1.04% 1.02% 1.05% 1.17% 1.43% 1.13% 1.19% 1.12% 1.38%
Earnings Yield
3.12% 3.17% 2.53% 2.33% 2.13% 2.24% 2.27% 1.75% 2.00% 1.83% 2.07%
Enterprise Value to Invested Capital (EV/IC)
2.52 2.49 2.91 2.95 2.81 2.49 2.02 1.87 4.24 4.58 3.77
Enterprise Value to Revenue (EV/Rev)
3.52 3.41 4.01 4.06 4.08 3.86 3.44 3.62 3.45 3.68 3.11
Enterprise Value to EBITDA (EV/EBITDA)
19.29 18.97 22.13 23.43 25.54 25.41 22.77 28.75 26.12 28.02 25.07
Enterprise Value to EBIT (EV/EBIT)
30.41 29.86 34.82 38.24 42.70 41.61 35.12 44.53 38.21 41.51 38.87
Enterprise Value to NOPAT (EV/NOPAT)
35.94 35.39 39.41 43.20 47.20 45.51 45.48 45.14 38.49 40.53 34.71
Enterprise Value to Operating Cash Flow (EV/OCF)
25.04 23.15 29.58 28.28 34.29 34.00 31.25 38.23 29.85 34.13 36.55
Enterprise Value to Free Cash Flow (EV/FCFF)
84.63 53.53 44.55 35.25 0.00 0.00 0.00 0.00 49.19 53.55 43.55
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.18 0.19 0.19 0.19 0.22 0.22 0.23 0.25 0.52 0.54 0.73
Long-Term Debt to Equity
0.18 0.18 0.19 0.19 0.19 0.22 0.23 0.23 0.52 0.54 0.58
Financial Leverage
0.11 0.10 0.13 0.15 0.17 0.16 0.21 0.24 0.35 0.30 0.38
Leverage Ratio
1.53 1.55 1.56 1.57 1.73 1.76 1.82 1.85 2.38 2.41 2.57
Compound Leverage Factor
1.47 2.50 1.50 1.51 1.61 1.65 1.70 1.68 2.22 2.26 1.51
Debt to Total Capital
15.42% 15.63% 15.83% 16.18% 18.20% 18.33% 18.59% 20.19% 34.39% 34.92% 42.31%
Short-Term Debt to Total Capital
0.31% 0.29% 0.14% 0.14% 2.28% 0.13% 0.14% 1.93% 0.00% 0.00% 8.65%
Long-Term Debt to Total Capital
15.10% 15.34% 15.70% 16.05% 15.91% 18.20% 18.45% 18.26% 34.39% 34.92% 33.66%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
1.82% 1.86% 0.06% 0.06% 0.06% 0.08% 0.09% 0.09% 0.20% 0.17% 0.13%
Common Equity to Total Capital
82.76% 82.51% 84.11% 83.76% 81.74% 81.59% 81.32% 79.72% 65.41% 64.91% 57.56%
Debt to EBITDA
1.29 1.31 1.31 1.37 1.79 2.04 2.22 3.29 2.50 2.59 3.57
Net Debt to EBITDA
0.61 0.58 0.66 0.81 1.04 1.13 1.53 2.36 1.39 1.29 1.78
Long-Term Debt to EBITDA
1.26 1.28 1.29 1.36 1.56 2.03 2.21 2.98 2.50 2.59 2.84
Debt to NOPAT
2.40 2.44 2.32 2.53 3.31 3.65 4.44 5.17 3.69 3.75 4.94
Net Debt to NOPAT
1.14 1.08 1.17 1.50 1.93 2.02 3.06 3.71 2.05 1.87 2.46
Long-Term Debt to NOPAT
2.35 2.39 2.30 2.51 2.89 3.63 4.41 4.67 3.69 3.75 3.93
Altman Z-Score
4.14 3.97 4.60 4.61 4.15 3.60 2.97 2.66 3.98 4.01 3.13
Noncontrolling Interest Sharing Ratio
1.16% 1.19% 0.09% 0.09% 0.14% 0.14% 0.14% 0.14% 0.28% 0.25% 0.25%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.89 1.75 1.96 1.85 1.67 1.76 1.72 1.64 2.01 1.89 1.65
Quick Ratio
1.29 1.19 1.31 1.22 1.11 1.20 1.11 1.04 1.31 1.28 1.14
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-306 -48 127 377 -6,730 -6,735 -6,950 -7,123 -8.07 33 22
Operating Cash Flow to CapEx
50.00% 580.81% 420.27% 405.63% 121.92% 478.95% 518.06% 51.85% -38.78% 613.56% 381.13%
Free Cash Flow to Firm to Interest Expense
-38.28 -5.32 12.69 34.25 -480.70 -481.05 -496.43 -593.58 -0.90 2.56 1.80
Operating Cash Flow to Interest Expense
4.13 63.89 31.10 26.18 6.36 32.50 26.64 2.33 -2.11 27.85 16.83
Operating Cash Flow Less CapEx to Interest Expense
-4.13 52.89 23.70 19.73 1.14 25.71 21.50 -2.17 -7.56 23.31 12.42
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.53 0.53 0.53 0.53 0.67 0.61 0.56 0.50 0.71 0.68 0.66
Accounts Receivable Turnover
5.08 5.21 5.01 5.04 5.75 5.43 5.06 4.51 5.34 5.39 5.36
Inventory Turnover
5.21 5.31 4.89 4.82 5.30 5.12 4.40 3.77 4.26 4.59 4.40
Fixed Asset Turnover
7.48 7.38 7.36 7.34 8.97 8.19 7.86 6.91 8.99 8.67 8.88
Accounts Payable Turnover
5.63 5.42 5.67 5.56 6.06 5.50 5.40 4.66 5.19 5.05 5.58
Days Sales Outstanding (DSO)
71.83 70.02 72.79 72.47 63.46 67.24 72.19 80.85 68.35 67.72 68.06
Days Inventory Outstanding (DIO)
70.04 68.70 74.57 75.68 68.85 71.36 82.94 96.78 85.75 79.57 82.96
Days Payable Outstanding (DPO)
64.78 67.34 64.34 65.64 60.20 66.41 67.54 78.39 70.32 72.30 65.39
Cash Conversion Cycle (CCC)
77.10 71.38 83.03 82.51 72.10 72.18 87.60 99.24 83.79 74.99 85.62
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
12,010 11,721 11,605 11,531 11,526 11,441 11,506 11,709 4,633 4,439 4,399
Invested Capital Turnover
0.73 0.74 0.73 0.72 0.98 0.93 0.85 0.75 1.24 1.26 1.23
Increase / (Decrease) in Invested Capital
484 280 99 -178 6,893 7,002 7,107 7,219 111 122 97
Enterprise Value (EV)
30,228 29,234 33,810 34,073 32,407 28,459 23,249 21,908 19,642 20,341 16,596
Market Capitalization
29,034 28,099 32,798 32,883 31,076 27,184 21,673 20,098 18,587 19,396 15,412
Book Value per Share
$44.50 $43.80 $43.61 $42.65 $42.15 $42.17 $41.23 $54.81 $19.85 $19.39 $17.84
Tangible Book Value per Share
$1.74 $1.16 $2.77 $1.89 $0.96 $0.21 ($1.07) ($2.20) ($0.42) ($0.86) ($1.97)
Total Capital
13,069 12,898 12,594 12,346 12,473 12,460 12,211 12,417 5,470 5,383 5,585
Total Debt
2,015 2,016 1,994 1,998 2,270 2,284 2,270 2,507 1,881 1,880 2,363
Total Long-Term Debt
1,974 1,978 1,977 1,981 1,985 2,268 2,253 2,267 1,881 1,880 1,880
Net Debt
956 895 1,005 1,183 1,323 1,265 1,565 1,799 1,044 936 1,177
Capital Expenditures (CapEx)
66 99 74 71 73 95 72 54 49 59 53
Debt-free, Cash-free Net Working Capital (DFCFNWC)
900 679 989 941 900 676 843 985 679 478 559
Debt-free Net Working Capital (DFNWC)
1,959 1,800 1,978 1,756 1,847 1,695 1,548 1,693 1,516 1,422 1,745
Net Working Capital (NWC)
1,918 1,762 1,961 1,739 1,562 1,679 1,531 1,453 1,516 1,422 1,262
Net Nonoperating Expense (NNE)
11 -94 8.87 4.71 10 1.27 4.93 4.04 3.93 6.31 107
Net Nonoperating Obligations (NNO)
956 839 1,005 1,183 1,323 1,265 1,565 1,799 1,044 936 1,177
Total Depreciation and Amortization (D&A)
145 142 141 145 134 137 147 92 60 60 58
Debt-free, Cash-free Net Working Capital to Revenue
10.47% 7.93% 11.74% 11.21% 11.32% 9.18% 12.49% 16.26% 11.92% 8.66% 10.47%
Debt-free Net Working Capital to Revenue
22.78% 21.02% 23.48% 20.91% 23.24% 23.02% 22.93% 27.96% 26.61% 25.75% 32.68%
Net Working Capital to Revenue
22.31% 20.58% 23.28% 20.71% 19.65% 22.80% 22.67% 23.99% 26.61% 25.75% 23.64%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.69 $1.35 $0.89 $0.80 $0.63 $1.18 $0.63 $0.45 $0.55 $0.83 $0.07
Adjusted Weighted Average Basic Shares Outstanding
243.11M 242.58M 242.93M 242.57M 241.85M 217.01M 240.87M 205.54M 180.40M 180.22M 180.22M
Adjusted Diluted Earnings per Share
$0.69 $1.33 $0.89 $0.80 $0.63 $1.17 $0.63 $0.45 $0.54 $0.82 $0.07
Adjusted Weighted Average Diluted Shares Outstanding
243.78M 243.52M 243.75M 243.54M 243.02M 218.18M 242.19M 206.74M 181.32M 180.98M 180.94M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
243.35M 243.05M 242.94M 242.89M 242.45M 241.77M 241.08M 240.83M 180.62M 180.28M 180.22M
Normalized Net Operating Profit after Tax (NOPAT)
194 254 229 217 171 161 174 119 109 161 129
Normalized NOPAT Margin
9.37% 11.25% 10.89% 9.99% 8.41% 7.60% 8.39% 6.89% 7.54% 10.68% 9.36%
Pre Tax Income Margin
10.49% 16.62% 12.79% 11.39% 9.64% 9.92% 8.91% 6.62% 8.70% 12.55% 1.23%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
28.13 25.78 27.90 23.45 15.00 16.00 14.21 10.50 15.00 15.54 2.42
NOPAT to Interest Expense
22.22 25.79 22.59 18.06 11.65 19.09 11.21 8.00 11.44 11.95 9.88
EBIT Less CapEx to Interest Expense
19.88 14.78 20.50 17.00 9.79 9.21 9.07 6.00 9.56 11.00 -2.00
NOPAT Less CapEx to Interest Expense
13.97 14.79 15.19 11.61 6.44 12.30 6.07 3.50 5.99 7.41 5.47
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
39.82% 39.33% 41.33% 43.79% 49.32% 49.10% 55.49% 69.89% 59.68% 61.13% 67.08%
Augmented Payout Ratio
41.81% 41.57% 45.42% 48.24% 54.15% 53.20% 57.52% 72.44% 62.10% 75.77% 83.39%

Frequently Asked Questions About Xylem's Financials

When does Xylem's fiscal year end?

According to the most recent income statement we have on file, Xylem's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Xylem's net income changed over the last 9 years?

Xylem's net income appears to be on an upward trend, with a most recent value of $890 million in 2024, rising from $340 million in 2015. The previous period was $609 million in 2023. See Xylem's forecast for analyst expectations on what’s next for the company.

What is Xylem's operating income?
Xylem's total operating income in 2024 was $1.01 billion, based on the following breakdown:
  • Total Gross Profit: $3.21 billion
  • Total Operating Expenses: $2.20 billion
How has Xylem revenue changed over the last 9 years?

Over the last 9 years, Xylem's total revenue changed from $3.65 billion in 2015 to $8.56 billion in 2024, a change of 134.4%.

How much debt does Xylem have?

Xylem's total liabilities were at $5.61 billion at the end of 2024, a 5.5% decrease from 2023, and a 118.1% increase since 2015.

How much cash does Xylem have?

In the past 9 years, Xylem's cash and equivalents has ranged from $296 million in 2018 to $1.88 billion in 2020, and is currently $1.12 billion as of their latest financial filing in 2024.

How has Xylem's book value per share changed over the last 9 years?

Over the last 9 years, Xylem's book value per share changed from 11.62 in 2015 to 43.80 in 2024, a change of 277.0%.



This page (NYSE:XYL) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners